Evidence map›Paper›PMID 31087023›Full record

ArticleJAMA2019

Association of Unrecognized Obstructive Sleep Apnea With Postoperative Cardiovascular Events in Patients Undergoing Major Noncardiac Surgery.

Matthew T V Chan, Chew Yin Wang, Edwin Seet, Stanley Tam, Hou Yee Lai, Eleanor F F Chew, William K K Wu, Benny C P Cheng, Carmen K M Lam, Timothy G Short and 3 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in JAMA, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05978505 (Reboxetine for Obstructive Sleep Apnoea After Upper Airway Surgery), which is not on this map. Cited by 119 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 3 pooled it
21.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05978505 phase2recruitingnot on this mapstarted 2023, after this paper: background citation

Reboxetine for Obstructive Sleep Apnoea After Upper Airway Surgery: a Randomised, Double-blind, Placebo-controlled Study

TypeinterventionalSponsorFlinders UniversityRan2023 to 2025Enrolled20ConditionsSleep Apnea, ObstructiveArmsReboxetine 4 MG Oral Tablet, Placebo
3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 3 syntheses or guidelines pooled it, 268 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 6 countries.

Matthew T V ChanChinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Chew Yin WangUniversity of Malaya, Kuala Lumpur, Malaysia.
Edwin SeetKhoo Teck Puat Hospital, Singapore.
Stanley TamScarborough Health Network, Ontario, Canada.
Hou Yee LaiUniversity of Malaya, Kuala Lumpur, Malaysia.
Eleanor F F ChewHospital Kuala Lumpur, Kuala Lumpur, Malaysia.
William K K WuChinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Benny C P ChengTuen Mun Hospital, Hong Kong Special Administrative Region, China.
Carmen K M LamTuen Mun Hospital, Hong Kong Special Administrative Region, China.
Timothy G ShortAuckland City Hospital, Auckland, New Zealand.
David S C HuiChinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Frances ChungToronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Postoperative Vascular Complications in Unrecognized Obstructive Sleep Apnea (POSA) Study Investigators
Chinese University of Hong Kong · HKTuen Mun Hospital · CNUniversity of Malaya · MYAuckland City Hospital · NZHospital Kuala Lumpur · MYKhoo Teck Puat Hospital · SGThe Scarborough Hospital · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Unrecognized obstructive sleep apnea increases cardiovascular risks in the general population, but whether obstructive sleep apnea poses a similar risk in the perioperative period remains uncertain. Objectives: To determine the association between obstructive sleep apnea and 30-day risk of cardiovascular complications after major noncardiac surgery. Design, Setting, and Participants: Prospective cohort study involving adult at-risk patients without prior diagnosis of sleep apnea and undergoing major noncardiac surgery from 8 hospitals in 5 countries between January 2012 and July 2017, with follow-up until August 2017. Postoperative monitoring included nocturnal pulse oximetry and measurement of cardiac troponin concentrations. Exposures: Obstructive sleep apnea was classified as mild (respiratory event index [REI] 5-14.9 events/h), moderate (REI 15-30), and severe (REI >30), based on preoperative portable sleep monitoring. Main Outcomes and Measures: The primary outcome was a composite of myocardial injury, cardiac death, heart failure, thromboembolism, atrial fibrillation, and stroke within 30 days of surgery. Proportional-hazards analysis was used to determine the association between obstructive sleep apnea and postoperative cardiovascular complications. Results: Among a total of 1364 patients recruited for the study, 1218 patients (mean age, 67 [SD, 9] years; 40.2% women) were included in the analyses. At 30 days after surgery, rates of the primary outcome were 30.1% (41/136) for patients with severe OSA, 22.1% (52/235) for patients with moderate OSA, 19.0% (86/452) for patients with mild OSA, and 14.2% (56/395) for patients with no OSA. OSA was associated with higher risk for the primary outcome (adjusted hazard ratio [HR], 1.49 [95% CI, 1.19-2.01]; P = .01); however, the association was significant only among patients with severe OSA (adjusted HR, 2.23 [95% CI, 1.49-3.34]; P = .001) and not among those with moderate OSA (adjusted HR, 1.47 [95% CI, 0.98-2.09]; P = .07) or mild OSA (adjusted HR, 1.36 [95% CI, 0.97-1.91]; P = .08) (P = .01 for interaction). The mean cumulative duration of oxyhemoglobin desaturation less than 80% during the first 3 postoperative nights in patients with cardiovascular complications (23.1 [95% CI, 15.5-27.7] minutes) was longer than in those without (10.2 [95% CI, 7.8-10.9] minutes) (P < .001). No significant interaction effects on perioperative outcomes were observed with type of anesthesia, use of postoperative opioids, and supplemental oxygen therapy. Conclusions and Relevance: Among at-risk adults undergoing major noncardiac surgery, unrecognized severe obstructive sleep apnea was significantly associated with increased risk of 30-day postoperative cardiovascular complications. Further research would be needed to assess whether interventions can modify this risk.

Indexed as

AgedCardiovascular DiseasesFemaleHumansHypoxiaKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisPolysomnographyPostoperative ComplicationsProspective StudiesRisk FactorsSleep Apnea, ObstructiveSurgical Procedures, Operative

Identifiers

PMID31087023
PMCPMC6518343
OpenAlexW2946132447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.